Uecker Darrin's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Sep 18, 2025
- Accession no.
- 0001437749-25-029432
- Filed
- Sep 18, 2025
- Trade date
- Sep 16-17, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $731.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Uecker DarrinCIK 0001276311 | Director, Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | Common Stock | MOption exerciseAcquired | +25,000 | $4.00 | +$100,000 | 147,872 | Direct | |
| Sep 16, 2025 | Common Stock | SSaleDisposed | −25,000 | $16.28 | −$407,000 | 122,872 | Direct | |
| Sep 17, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $4.00 | +$80,000 | 142,872 | Direct | |
| Sep 17, 2025 | Common Stock | SSaleDisposed | −20,000 | $16.21 | −$324,200 | 122,872 | Direct | |
| Sep 17, 2025 | Common Stock | MOption exerciseAcquired | +61,534 | $4.00 | +$246,136 | 184,406 | Direct | |
| Sep 17, 2025 | Common Stock | MOption exerciseAcquired | +100,000 | $4.00 | +$400,000 | 284,406 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | Common Stock | MOption exerciseDisposed | −25,000 | $0.00 | $0 | 81,534 | Direct | |
| Sep 17, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 61,534 | Direct | |
| Sep 17, 2025 | Common Stock | MOption exerciseDisposed | −61,534 | $0.00 | $0 | 0 | Direct | |
| Sep 17, 2025 | Common Stock | MOption exerciseDisposed | −100,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.